FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

20450009: Ciprofloxacin hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
34414017 Ciprofloxacin hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
34415016 Bay-Q 3939 en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
34416015 Bay-o 9867 monohydrate en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
749600015 Ciprofloxacin hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
45161000188114 ciprofloxacine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
801041000172117 chlorhydrate de ciprofloxacine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ciprofloxacin hydrochloride Is a Product containing ciprofloxacin (medicinal product) false Inferred relationship Some
Ciprofloxacin hydrochloride Is a Ciprofloxacin (substance) false Inferred relationship Some
Ciprofloxacin hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Ciprofloxacin (substance) true Inferred relationship Some
Ciprofloxacin hydrochloride Is a Quinolone antibacterial false Inferred relationship Some
Ciprofloxacin hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Ciprofloxacin hydrochloride Is a Fluoroquinolone (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely ciprofloxacin hydrochloride 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Product containing precisely ciprofloxacin hydrochloride 250 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Product containing precisely ciprofloxacin hydrochloride 500 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Product containing precisely ciprofloxacin hydrochloride 750 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Ciprofloxacin hydrochloride 0.3% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Ciprofloxacin hydrochloride 3.5mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Ciprofloxacin 0.2% + hydrocortisone 1% otic solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Ciprofloxacin+hydrocortisone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some
Product containing precisely ciprofloxacin hydrochloride 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 100 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 250 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 250 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 500 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 500 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 750 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 750 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 100 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 250 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 500 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin hydrochloride 750 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ciprofloxacin hydrochloride Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin hydrochloride) 750 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin hydrochloride) 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ciprofloxacin hydrochloride Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 2
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram and tinidazole 300 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter and fluocinolone acetonide 250 microgram/1 milliliter conventional release solution for ear drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter conventional release solution for ear drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin hydrochloride) 574.9 mg and ciprofloxacin 425.2 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start